![Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael](https://journals.sagepub.com/cms/10.1177/0269881115599385/asset/images/large/10.1177_0269881115599385-fig1.jpeg)
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael
![PDF) Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale PDF) Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale](https://i1.rgstatic.net/publication/23267285_Better_sexual_acceptability_of_agomelatine_25_and_50_mg_compared_with_paroxetine_20_mg_in_healthy_male_volunteers_An_8-week_placebo-controlled_study_using_the_PRSEXDQ-SALSEX_scale/links/0fcfd50216cd106508000000/largepreview.png)
PDF) Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
![Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20180606105343-16438-mediumThumb-S0007125000240397_fig1g.jpg?pub-status=live)
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core
![Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael](https://journals.sagepub.com/cms/10.1177/0269881115599385/asset/images/large/10.1177_0269881115599385-fig2.jpeg)
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale - Angel L Montejo, JFW Deakin, Raphael
![PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder](https://i1.rgstatic.net/publication/353632699_Drug_use_evaluation_A_two-year_retrospective_review_of_the_effectiveness_and_tolerability_of_agomelatine_versus_mirtazapine_in_patients_with_depressive_disorder/links/61073bc10c2bfa282a15acc8/largepreview.png)
PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder
![EP2058296A1 - New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof - Google Patents EP2058296A1 - New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof - Google Patents](https://patentimages.storage.googleapis.com/1d/b4/6b/887b7aa56db0dd/imgb0002.png)
EP2058296A1 - New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof - Google Patents
Agomelatine Teva Läs noga igenom denna bipacksedel innan du börjar ta detta läkemedel. Den innehåller information som är v
![Mike Zaworotko group on X: "Cocrystals here there and everywhere - part 2 Cocrystals are a major research theme @SSPCentre EMA + FDA green light pharmaceutical cocrystals as active drug substances; generic Mike Zaworotko group on X: "Cocrystals here there and everywhere - part 2 Cocrystals are a major research theme @SSPCentre EMA + FDA green light pharmaceutical cocrystals as active drug substances; generic](https://pbs.twimg.com/media/FATpL4nXIAAd_1q.jpg)
Mike Zaworotko group on X: "Cocrystals here there and everywhere - part 2 Cocrystals are a major research theme @SSPCentre EMA + FDA green light pharmaceutical cocrystals as active drug substances; generic
PRODUKTRESUMÉ 1. LÄKEMEDLETS NAMN Agomelatine Teva 25 mg filmdragerade tabletter 2. KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING
![Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/754e9ade-a43c-4c59-8d48-3ba7cf5a5b38/gr2_lrg.jpg)